G2-T

G2-T is selected for protocols exploring two incretin receptor pathways in a single compound. Unlike single-receptor studies, this format lets researchers track layered receptor signals within one model. Focus areas include:

• Dual-receptor signaling across GLP-1 and GIP
• Receptor binding and structure-activity mapping
• Comparative pathway characterization in non-human and in vitro systems
• Short-duration protocols requiring combined receptor activation

Each batch is independently third-party tested to meet research-only classification standards.

1. Why study GLP-1 and GIP together? The two receptor families are often examined in combination to understand how layered receptor signals behave in non-human research.

2. How does a dual-receptor compound differ from a single-receptor one? Dual-receptor compounds like G2-T are used when the goal is to examine combined signaling across two receptor systems within the same model.

3. What types of studies use G2-T? Receptor binding, signaling, and structure-activity characterization in non-human and in vitro models.

4. Is this for human or animal use? No. All KÖLD products are for Research Use Only and are not intended for human or animal consumption, diagnosis, or treatment.

5. How is it supplied? G2-T is supplied as a lyophilized powder and is reconstituted only if a protocol requires it.

Before Reconstitution

Freeze at -20°C (-4°F)

Store sealed and protected from light and moisture

After Reconstitution

Refrigerate at 4°C (39°F)

Use within 14 days

Avoid freeze-thaw cycles

This compound is supplied as a lyophilized powder.
Use KÖLD Solution (sterile, lab-grade solvent) if your protocol requires reconstitution.
Reconstitute only when ready to begin your study.
For research use only. Not for human or animal use.
Not intended to diagnose, treat, cure, or prevent any disease.